CVE-2026-19543: IBM Common Licensing · Improper Input Validation
Affects IBM Common LicensingSource CVE Database V5
Not known to be exploited · CVSS 6.2 Medium.
Data as of 29 Oct 2026, 19:04 UTC
- EPSS
- 0.1% chance of exploitation in 30 days – higher than 6% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:HExploitation evidence
Disclosed: evidence found.
CVE published 14 Sep 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 29 Oct 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| IBMCommon Licensing | Affected
| Fixed in– |
CPE configurations (2)
cpe:2.3:a:ibm:common_licensing:agent:*:*:*:*:*:*:*cpe:2.3:a:ibm:common_licensing:art:*:*:*:*:*:*:*
AI-suggested
Until a fix is available, consider restricting access to the affected components and monitoring for anomalous input patterns that may indicate exploitation attempts.
Description
IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 performs input validation exclusively on the client side and fails to enforce the same restrictions on the server side. An attacker can modify requests to bypass validation controls and submit unauthorized values, potentially resulting in unintended application behavior.